Joanna S. Remack

835 total citations
21 papers, 719 citations indexed

About

Joanna S. Remack is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Joanna S. Remack has authored 21 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Neurology. Recurrent topics in Joanna S. Remack's work include DNA Repair Mechanisms (13 papers), Epigenetics and DNA Methylation (9 papers) and Pluripotent Stem Cells Research (5 papers). Joanna S. Remack is often cited by papers focused on DNA Repair Mechanisms (13 papers), Epigenetics and DNA Methylation (9 papers) and Pluripotent Stem Cells Research (5 papers). Joanna S. Remack collaborates with scholars based in United States, Canada and South Korea. Joanna S. Remack's co-authors include Thomas P. Brent, Linda C. Harris, Philip M. Potter, Karina J. Yoon, Mary K. Danks, Marianne Z. Metz, Joseph Najbauer, Elizabeth Garcia, Karen S. Aboody and Seung Up Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Joanna S. Remack

21 papers receiving 709 citations

Peers

Countries citing papers authored by Joanna S. Remack

Since Specialization

Citations

This map shows the geographic impact of Joanna S. Remack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna S. Remack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna S. Remack more than expected).

Fields of papers citing papers by Joanna S. Remack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna S. Remack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna S. Remack. The network helps show where Joanna S. Remack may publish in the future.

Co-authorship network of co-authors of Joanna S. Remack

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna S. Remack. A scholar is included among the top collaborators of Joanna S. Remack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna S. Remack. Joanna S. Remack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma 2008 ·PLoS ONE ·Karina J. Yoon, Doris A. Phelps, (unknown), Joanna S. Remack, Catherine A. Billups, Joseph D. Khoury	23
2	Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma 2007 ·Cancer Research ·Mary K. Danks, Karina J. Yoon, (unknown), Joanna S. Remack, Monika Wierdl, Lyudmila Tsurkan, Seung Up Kim, Elizabeth Garcia, Marianne Z. Metz, Joseph Najbauer, Philip M. Potter, Karen S. Aboody	114
3	Development of a Tumor-Selective Approach to Treat Metastatic Cancer 2006 ·PLoS ONE ·Karen S. Aboody, (unknown), Elizabeth Garcia, Marianne Z. Metz, Joseph Najbauer, Kristine A. Justus, Doris A. Phelps, Joanna S. Remack, Karina J. Yoon, (unknown), Seung Up Kim, Carlotta A. Glackin, Philip M. Potter, Mary K. Danks	108
4	Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy 2006 ·Molecular Cancer Therapeutics ·Karina J. Yoon, Jianjun Qi, Joanna S. Remack, Kristopher G. Virga, M. Jason Hatfield, Philip M. Potter, Richard Lee, Mary K. Danks	4
5	1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O 6 -alkylguanine-DNA alkyltransferase in cytotoxicity 2004 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Joanna S. Remack, Thomas P. Brent, Alan C. Sartorelli, Raymond P. Baumann	27
6	1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O 6 -alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition 2004 ·Cancer Chemotherapy and Pharmacology ·Philip G. Penketh, (unknown), Raymond P. Baumann, Joanna S. Remack, Thomas P. Brent, Alan C. Sartorelli	29
7	Heterogeneous methylation of the O6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines 2001 ·International Journal of Oncology ·Rebecca P. Danam, (unknown), Joanna S. Remack, Thomas P. Brent	17
8	Extraneuronal monoamine transporter expression and DNA repair vis-à-vis 2-chloroethyl-3-sarcosinamide-1-nitrosourea cytotoxicity in human tumor cell lines. 1999 ·PubMed ·(unknown), Joanna S. Remack, Thomas P. Brent, Gérard Mohr, Lawrence Panasci	10
9	A specific CpG methylation pattern of theMGMT promoter region associated with reduced MGMT expression in primary colorectal cancers 1999 ·Molecular Carcinogenesis ·Klaus Herfarth, Thomas P. Brent, Rebecca P. Danam, Joanna S. Remack, Ira J. Kodner, Samuel A. Wells, Paul J. Goodfellow	68
10	Evidence for Nucleotide Excision Repair as a Modifying Factor ofO6-Methylguanine-DNA Methyltransferase-Mediated Innate Chloroethylnitrosourea Resistance in Human Tumor Cell Lines 1997 ·Molecular Pharmacology ·Zhong-Ping Chen, Areti Malapetsa, (unknown), Daniela Di Marcantonio, (unknown), Gérard Mohr, Joanna S. Remack, Thomas P. Brent, Lawrence Panasci	36
11	Changes in O⁶-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts 1996 ·Carcinogenesis ·Linda C. Harris, Mathew A. von Wronski, (unknown), Joanna S. Remack, (unknown), Thomas P. Brent	21
12	Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O⁶-methylguanine DNA methyltransferease gene 1994 ·Nucleic Acids Research ·Linda C. Harris, Joanna S. Remack, Thomas P. Brent	37
13	In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription 1994 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Linda C. Harris, Joanna S. Remack, Thomas P. Brent	25
14	Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression. 1993 ·PubMed ·Philip M. Potter, Linda C. Harris, Joanna S. Remack, (unknown), Thomas P. Brent	19
15	A comparison of human O6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer- cells. 1992 ·PubMed ·Linda C. Harris, Philip M. Potter, Joanna S. Remack, Thomas P. Brent	18
16	The origin of O6-methylguanine-DNA methyltransferase in Chinese hamster overy cells transfected with human DNA 1991 ·Mutation Research/DNA Repair ·Keizo Tano, Susumu Shiota, Joanna S. Remack, Thomas P. Brent, Darell D. Bigner, Sankar Mitra	8
17	Formation of covalent complexes between humanO⁶alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides 1988 ·Nucleic Acids Research ·Thomas P. Brent, Joanna S. Remack	50
18	Characterization of a novel reaction by human O6-alkylguanine-DNA alkyltransferase with 1,3-bis(2-chloroethyl)-1-nitrosourea-treated DNA. 1987 ·PubMed ·Thomas P. Brent, Joanna S. Remack, (unknown)	18
19	Evidence that O6-alkylguanine-DNA alkyltransferase becomes covalently bound to DNA containing 1,3-bis(2-chloroethyl)-1-nitrosourea-induced precursors of interstrand cross-links 1987 ·Biochemical and Biophysical Research Communications ·Thomas P. Brent, (unknown), Joanna S. Remack	22
20	Formation of DNA interstrand cross-links by the novel chloroethylating agent 2-chloroethyl(methylsulfonyl)methanesulfonate: suppression by O6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts. 1987 ·PubMed ·Thomas P. Brent, (unknown), (unknown), Joanna S. Remack	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact